Clinical and biochemical manifestations of depression: Relation to the neurobiology of stress

Neural Plasticity

Volumn 2015, Issue , 2015, Pages

  Gold, Phillip W ^a   Machado Vieira, Rodrigo ^a   Pavlatou, Maria G ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR; INSULIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ACUTE STRESS; ADAPTATION; AGRANULOCYTOSIS; AMYGDALOID NUCLEUS; ANTIDEPRESSANT ACTIVITY; ATYPICAL DEPRESSION; BEHAVIOR; BLEEDING; BRAIN METABOLISM; CARDIOVASCULAR EFFECT; CLINICAL FEATURE; COGNITION; DRUG MECHANISM; DRUG SAFETY; FEAR; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; HYPONATREMIA; INSULIN RESISTANCE; LOCUS CERULEUS; MAJOR DEPRESSION; MELANCHOLIA; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; REVIEW; SEIZURE; SEROTONINERGIC SYSTEM; STRESS; THROMBOSIS; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; ANIMAL; BRAIN; COMPLICATION; DEPRESSIVE DISORDER; INFLAMMATION; MENTAL STRESS; PHYSIOLOGICAL STRESS;

ANIMALS; BRAIN; DEPRESSIVE DISORDER; HOMEOSTASIS; HUMANS; INFLAMMATION; NEUROGENESIS; NEURONAL PLASTICITY; OXIDATIVE STRESS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84927154688     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2015/581976     Document Type: Review

References (55)

1. K. S. Kendler, M. C. Neale, R. C. Kessler, A. C. Heath, and L. J. Eaves, "The lifetime history of major depression in women: reliability of diagnosis and heritability, " Archives of General Psychiatry, vol. 50, no. 11, pp. 863-870, 1993.
2. H.-U. Wittchen, B. Knauper, and R. C. Kessler, "Lifetime risk of depression, " British Journal of Psychiatry, vol. 165, no. 26, pp. 16-22, 1994.
3. E. Frank and M. E. Thase, "Natural history and preventative treatment of recurrent mood disorders, " Annual Review of Medicine, vol. 50, pp. 453-468, 1999.
4. P. W. Gold, "The neurobiology of stress and its relevance to psychotherapy, " Clinical Neuroscience Research, vol. 4, no. 5-6, pp. 315-324, 2005.
5. P. W. Gold and G. P. Chrousos, "Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states, " Molecular Psychiatry, vol. 7, no. 3, pp. 254-275, 2002.
6. S. B. Guze and E. Robins, "Suicide and primary affective disorders, " British Journal of Psychiatry, vol. 117, no. 539, pp. 437-438, 1970.
7. G. P. Chrousos and P. W. Gold, "The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis, " Journal of the AmericanMedical Association, vol. 267, no. 9, pp. 1244-1252, 1992.
8. P. W. Gold, F. K. Goodwin, and G. P. Chrousos, "Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress, " The New England Journal of Medicine, vol. 319, no. 6, pp. 348-353, 1988.
9. P. W. Gold, F. K. Goodwin, and G. P. Chrousos, "Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2), " The New England Journal of Medicine, vol. 319, no. 7, pp. 413-420, 1988.
10. R. And a, D. Williamson, D. Jones et al. , "Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U. S. adults, " Epidemiology, vol. 4, no. 4, pp. 285-294, 1993.
11. J. C. Barefoot and M. Schroll, "Symptoms of depression, acute myocardial infarction, and total mortality in a community sample, " Circulation, vol. 93, no. 11, pp. 1976-1980, 1996.
12. B. W. J. H. Penninx, J. M. Guralnik, C. F. Mendes de Leon et al. , "Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age, " The American Journal of Cardiology, vol. 81, no. 8, pp. 988-994, 1998.
13. B. W. J. H. Penninx, S. W. Geerlings, D. J. H. Deeg, J. T. M. van Eijk, W. van Tilburg, and A. T. F. Beekman, "Minor and major depression and the risk of death in older persons, " Archives of General Psychiatry, vol. 56, no. 10, pp. 889-895, 1999.
14. P. A. Shapiro, L. Lidagoster, and A. H. Glassman, "Depression and heart disease, " Psychiatric Annals, vol. 27, no. 5, pp. 347-352, 1997.
15. D. Michelson, C. Stratakis, L. Hill et al. , "Bone mineral density in women with depression, " The New England Journal of Medicine, vol. 335, no. 16, pp. 1176-1181, 1996.
16. C. J. L. Murray and A. D. Lopez, "Evidence-based health policy-lessons from the global burden of disease study, " Science, vol. 274, no. 5288, pp. 740-743, 1996.
17. R. C. Kessler, K. A. McGonagle, S. Zhao et al. , "Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey, " Archives of General Psychiatry, vol. 51, no. 1, pp. 8-19, 1994.
18. K. S. Kendler, M. C. Neale, R. C. Kessler, A. C. Heath, and L. J. Eaves, "Childhood parental loss and adult psychopathology in women: a twin study perspective, " Archives of General Psychiatry, vol. 49, no. 2, pp. 109-116, 1992.
19. K. S. Kendler, R. C. Kessler, E. E. Waiters et al. , "Stressful life events, genetic liability, and onset of an episode of major depression in women, " The American Journal of Psychiatry, vol. 152, no. 6, pp. 833-842, 1995.
20. J. E. LeDoux, "Emotion and the amygdala, " in The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfuction, J. P. Aggleton, Ed. , pp. 339-351, Wiley-Liss, New York, NY, USA, 1992.
21. J. E. LeDoux, "Emotion: clues from the brain, " Annual Review of Psychology, vol. 46, pp. 209-235, 1995.
22. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, APA Press, 2000.
23. R. D. Levitan, A. Lesage, S. V. Parikh, P. Goering, and S. H. Kennedy, "Reversed neurovegetative symptoms of depression: a community study of Ontario, " The American Journal of Psychiatry, vol. 154, no. 7, pp. 934-940, 1997.
24. K. S. Kendler, L. J. Eaves, E. E. Walters, M. C. Neale, A. C. Heath, and R. C. Kessler, "The identification and validation of distinct depressive syndromes in a population-based sample of female twins, " Archives of General Psychiatry, vol. 53, no. 5, pp. 391-399, 1996.
25. M. E. Thase, "Diagnosis and treatment of a major depressive episode, "The Journal of Clinical Psychiatry, vol. 70, no. 10, p. e37, 2009.
26. L. Cahill, R. J. Haier, J. Fallon et al. , "Amygdala activity at encoding correlated with long-term, free recall of emotional information, " Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 15, pp. 8016-8021, 1996.
27. M. A. Kling, S. Alesci, G. Csako et al. , "Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase protein C-reactive protein and serum amyloid A, " Biological Psychiatry, vol. 62, no. 4, pp. 309-313, 2007.
28. J. M. Fuster, "The prefrontal cortex and its relation to behavior, " Progress in Brain Research, vol. 87, pp. 201-211, 1991.
29. D. Diorio, V. Viau, and M. J. Meaney, "The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress, " The Journal of Neuroscience, vol. 13, no. 9, pp. 3839-3847, 1993.
30. W. C. Drevets, J. L. Price, J. R. Simpson Jr. et al. , "Subgenual prefrontal cortex abnormalities inmood disorders, " Nature, vol. 386, no. 6627, pp. 824-827, 1997.
31. J. L. Mcgaugh, L. Cahill, and B. Roozendaal, "Involvement of the amygdala in memory storage: interaction with other brain systems, " Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 24, pp. 13508-13514, 1996.
32. M. G. Packard, L. Cahill, and J. L. Mcgaugh, "Amygdala modulation of hippocampal-dependent and caudate nucleusdependent memory processes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 18, pp. 8477-8481, 1994.
33. S. Zola-Morgan, L. R. Squire, P. Alvarez-Royo, and R. P. Clower, "Independence of memory functions and emotional behavior: separate contributions of the hippocampal formation and the amygdala, " Hippocampus, vol. 1, no. 2, pp. 207-220, 1991.
34. L. Cahill and J. L. McGaugh, "Mechanisms of emotional arousal and lasting declarative memory, " Trends in Neurosciences, vol. 21, no. 7, pp. 294-299, 1998.
35. G. MacQueen and T. Frodl, "The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research, " Molecular Psychiatry, vol. 16, no. 3, pp. 252-264, 2011.
36. J. S. Snyder, A. Soumier, M. Brewer, J. Pickel, and H. A. Cameron, "Adult hippocampal neurogenesis buffers stress responses and depressive behaviour, " Nature, vol. 476, no. 7361, pp. 458-462, 2011.
37. J. L. Price and W. C. Drevets, "Neural circuits underlying the pathophysiology of mood disorders, " Trends in Cognitive Sciences, vol. 16, no. 1, pp. 61-71, 2012.
38. K. C. Berridge and M. L. Kringelbach, "Neuroscience of affect: brain mechanisms of pleasure and displeasure, " Current Opinion in Neurobiology, vol. 23, no. 3, pp. 294-303, 2013.
39. D. A. Pizzagalli, A. J. Holmes, D. G. Dillon et al. , "Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder, "TheAmerican Journal of Psychiatry, vol. 166, no. 6, pp. 702-710, 2009.
40. P. W. Gold, D. L. Loriaux, A. Roy et al. , "Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushings disease: pathophysiologic and diagnostic implications, "The New England Journal of Medicine, vol. 314, no. 21, pp. 1329-1335, 1986.
41. M.-L. Wong, M. A. Kling, P. J. Munson et al. , "Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone, " Proceedings of the NationalAcademy of Sciences of theUnited States ofAmerica, vol. 97, no. 1, pp. 325-330, 2000.
42. L. S. Brady, H. J. Whitfield Jr. , R. J. Fox, P. W. Gold, and M. Herkenham, "Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications, " Journal of Clinical Investigation, vol. 87, no. 3, pp. 831-837, 1991.
43. L. S. Brady, P. W. Gold, M. Herkenham, A. B. Lynn, and H. J. Whitfield Jr. , "The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications, " Brain Research, vol. 572, no. 1-2, pp. 117-125, 1992.
44. M. A. Demitrack, J. K. Dale, S. E. Straus et al. , "Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome, " Journal of Clinical Endocrinology and Metabolism, vol. 73, no. 6, pp. 1224-1234, 1991.
45. J. R. Joseph-Vand erpool, N. E. Rosenthal, G. P. Chrousos et al. , "Abnormal pituitary-adrenal responses to corticotropinreleasing hormone in patients with seasonal affective disorder: clinical and pathophysiological implications, " Journal of Clinical Endocrinology and Metabolism, vol. 72, no. 6, pp. 1382-1387, 1991.
46. X. Feng, L. Wang, S. Yang et al. , "Maternal separation produces lasting changes in cortisol and behavior in rhesus monkeys, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 34, pp. 4312-4317, 2010.
47. R. S. Duman and L. M. Monteggia, "Aneurotrophicmodelforstress-relatedmood disorders, " Biological Psychiatry, vol. 59, no. 12, pp. 1116-1127, 2006.
48. V. Krishnan and E. J. Nestler, "The molecular neurobiology of depression, " Nature, vol. 455, no. 7215, pp. 894-902, 2008.
49. V. Duric, M. Banasr, P. Licznerski et al. , "A negative regulator of MAP kinase causes depressive behavior, " Nature Medicine, vol. 16, no. 11, pp. 1328-1332, 2010.
50. S. Makino, P. W. Gold, and J. Schulkin, "Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus, " Brain Research, vol. 640, no. 1-2, pp. 105-112, 1994.
51. M. J. Meaney, J. B. Mitchell, D. H. Aitken et al. , "The effects of neonatal hand ling on the development of the adrenocortical response to stress: implications for neuropathology and cognitive deficits in later life, " Psychoneuroendocrinology, vol. 16, no. 1-3, pp. 87-105, 1991.
52. V. Viau, S. Sharma, P. M. Plotsky, and M. J. Meaney, "Increased plasma ACTH responses to stress in nonhand led compared with hand led rats require basal levels of corticosterone and are associated with increased levels of ACTH secretagogues in the median eminence, " Journal of Neuroscience, vol. 13, no. 3, pp. 1097-1105, 1993.
53. K. S. Kendler and L. J. Eaves, "Models for the joint effect of genotype and environment on liability to psychiatric illness, " The American Journal of Psychiatry, vol. 143, no. 3, pp. 279-289, 1986.
54. X. Dong, I. E. Leppik, J. White, and J. Rarick, "Hyponatremia fromoxcarbazepine and carbamazepine, " Neurology, vol. 65, no. 12, pp. 1976-1978, 2005.
55. R. Mago, R. Mahajan, and M. E. Thase, "Medically serious adverse effects of newer antidepressants, " Current Psychiatry Reports, vol. 10, no. 3, pp. 249-257, 2008.